ID

12464

Beschrijving

The purpose of this study is to test the hypothesis that the onset of the antiplatelet effect of ticagrelor is more rapid and greater than clopidogrel in Chinese patients with ACS. https://clinicaltrials.gov/ct2/show/NCT01864005

Link

https://clinicaltrials.gov/ct2/show/NCT01864005

Trefwoorden

  1. 28-07-15 28-07-15 -
  2. 21-11-15 21-11-15 -
Geüploaded op

21 november 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility HouYi Acute Coronary Syndrome NCT01864005

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Beschrijving

Inclusion Criteria

Provision of informed consent prior to any study specific procedures
Beschrijving

Provision of informed consent prior to any study specific procedures

Datatype

boolean

Alias
UMLS CUI-1
C0021430
Female or male
Beschrijving

Female or male

Datatype

boolean

Alias
UMLS CUI-1
C0079399
Aged at least 18 years
Beschrijving

Aged at least 18 years

Datatype

boolean

Alias
UMLS CUI-1
C0001779
Females of child-bearing potential must have a negative urine pregnancy test at enrolment
Beschrijving

Females of child-bearing potential must have a negative urine pregnancy test at enrolment

Datatype

boolean

Alias
UMLS CUI-1
C0549206
Females of child-bearing potential must be willing to use reliable contraception
Beschrijving

Females of child-bearing potential must be willing to use reliable contraception

Datatype

boolean

Alias
UMLS CUI-1
C0009871
Index event of non-ST or ST segment elevation ACS.
Beschrijving

Index event of non-ST or ST segment elevation ACS.

Datatype

boolean

Alias
UMLS CUI [1]
C0948089
Exclusion Criteria
Beschrijving

Exclusion Criteria

Contraindication or other reason that clopidogrel should not be administered
Beschrijving

Contraindication or other reason that clopidogrel should not be administered

Datatype

boolean

Alias
UMLS CUI-1
C1319916
Contraindication or other reason that ticagrelor should not be administered
Beschrijving

Contraindication or other reason that ticagrelor should not be administered

Datatype

boolean

Alias
UMLS CUI-1
C1999375
UMLS CUI-2
C0522473
Oral anticoagulation therapy within 30 days prior to randomisation or cannot be stopped
Beschrijving

Oral anticoagulation therapy

Datatype

boolean

Alias
UMLS CUI-1
C0354604
GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped
Beschrijving

GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped

Datatype

boolean

Alias
UMLS CUI-1
C3640054
Ticagrelor within 14 days prior to randomisation
Beschrijving

Ticagrelor within 14 days prior to randomisation

Datatype

boolean

Alias
UMLS CUI-1
C1999375
Clopidogrel within 14 days prior to randomisation
Beschrijving

Clopidogrel or other P2Y12 inhibitors within 14 days prior to randomisation

Datatype

boolean

Alias
UMLS CUI-1
C0070166
P2Y12 inhibitors within 14 days prior to randomisation
Beschrijving

P2Y12 inhibitors within 14 days prior to randomisation

Datatype

boolean

Alias
UMLS CUI-1
C2936588
Requires dialysis
Beschrijving

Requires dialysis

Datatype

boolean

Alias
UMLS CUI-1
C0019004
Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped
Beschrijving

Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped

Datatype

boolean

Alias
UMLS CUI-1
C0003211
prostacyclins (PGI2) therapy that cannot be stopped
Beschrijving

prostacyclins (PGI2) therapy that cannot be stopped

Datatype

boolean

Alias
UMLS CUI-1
C2825061

Similar models

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of informed consent prior to any study specific procedures
boolean
C0021430 (UMLS CUI-1)
Gender
Item
Female or male
boolean
C0079399 (UMLS CUI-1)
Age
Item
Aged at least 18 years
boolean
C0001779 (UMLS CUI-1)
Pregnancy
Item
Females of child-bearing potential must have a negative urine pregnancy test at enrolment
boolean
C0549206 (UMLS CUI-1)
Contraceptive
Item
Females of child-bearing potential must be willing to use reliable contraception
boolean
C0009871 (UMLS CUI-1)
Acute coronary syndrome
Item
Index event of non-ST or ST segment elevation ACS.
boolean
C0948089 (UMLS CUI [1])
Item Group
Exclusion Criteria
Clopidogrel contraindicated
Item
Contraindication or other reason that clopidogrel should not be administered
boolean
C1319916 (UMLS CUI-1)
Ticagrelor contraindicated
Item
Contraindication or other reason that ticagrelor should not be administered
boolean
C1999375 (UMLS CUI-1)
C0522473 (UMLS CUI-2)
Oral anticoagulants
Item
Oral anticoagulation therapy within 30 days prior to randomisation or cannot be stopped
boolean
C0354604 (UMLS CUI-1)
GPIIb/IIIa receptor antagonist
Item
GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped
boolean
C3640054 (UMLS CUI-1)
Ticagrelor
Item
Ticagrelor within 14 days prior to randomisation
boolean
C1999375 (UMLS CUI-1)
Clopidogrel
Item
Clopidogrel within 14 days prior to randomisation
boolean
C0070166 (UMLS CUI-1)
Thienopyridines
Item
P2Y12 inhibitors within 14 days prior to randomisation
boolean
C2936588 (UMLS CUI-1)
Hemodialysis
Item
Requires dialysis
boolean
C0019004 (UMLS CUI-1)
NSAID
Item
Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped
boolean
C0003211 (UMLS CUI-1)
Prostacycline
Item
prostacyclins (PGI2) therapy that cannot be stopped
boolean
C2825061 (UMLS CUI-1)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial